Favourable results of early second-phase antirheumatic drugs in rheumatoid arthritis;Gunstige resultaten van vroege tweedefasemedicatie bij reumatoide artritis

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 15, 1997, Pages 732-736

  Van Jaarsveld, C H M ^a   Van Der Heide, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030906469     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wilske KR, Healey LA. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis. J Rheumatol 1990;25 Suppl:4-7.
2. Schuurman W, ALphen-Jager JM van, Bosch WJHM van den, Lagro HAHM, Willems D, Romeijnders ACM, et al. NHG-standaard Reumatoïde Artritis. Huisarts Wet 1994;37:248-59.
3. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
4. Fries JF. Safety issues related to DMARD therapy. J Rheumatol 1990;25 Suppl:14-7.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Heide A van der, Jacobs JWG, Bijlsma JWJ, Heurkens AHM, Booma-Frankfort C van, Veen MJ van der, et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
7. Heide A van der, Jacobs JWG, Dinant HJ, Bijlsma JWJ. The impact of endpoint measures in rheumatoid arthritis clinical trials. Semin Arthritis Rheum 1992;21:287-94.
8. Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:71-4.
9. Brink HR van den, Heide A van der, Jacobs JWG, Veen MJ van der, Bijlsma JWJ. Evaluation of the Thompson articular index. J Rheumatol 1993;20:28-32.
10. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
11. Goldsmith CH, Boers M, Bombardier C, Tugwell P. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol 1993;20:561-5.
12. Scott DL, Spector TD, Pullar T, McConkey B. What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis 1989;48:256-61.
13. Norusis MJ. SPSS/PC+ tm Base Manual. Chicago: SPSS Inc., 1988.
14. Riel PLCM van. Disease assessment and outcome in rheumatoid arthritis. Rheumatology in Europe 1994;23:128-9.
15. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting anti-rheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
16. Wijnands MJH, Hof MA van 't, Leeuwen MA van, Rijswijk MH van, Putte LBA van de, Riel PLCM van. Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol 1992; 31:253-8.
17. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med 1974;80:21-6.
18. Leeuwen MA van, Heijde DMFM van der, Rijswijk MH van, Houtman PM, Riel PL van, Putte LB van de, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.